Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...

Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.

Apple can continue selling redesigned Apple Watches with a blood oxygen feature after the International Trade Commission ...

Masimo MASI recently reported findings from the NeoPODS study, a large prospective real-world evaluation of its SET pulse oximetry technology in critically ill newborns. The study demonstrated less ...

Is MASI a good stock to buy? We came across a bullish thesis on Masimo Corporation on Valueinvestorsclub.com by GCA. In this ...

Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to ...

A Previously Banned Apple Watch Health Feature Is Now Here to Stay ...

An announcement from Masimo ( (MASI)) is now available. On May 1, 2026, Masimo shareholders approved the company’s merger agreement with Danaher Corporation at a virtual special meeting, with roughly ...

Apple can keep selling Apple Watches with its redesigned blood oxygen feature in the US after the ITC declined to revive ...

Recent announcements highlight major sensor innovations: a faster chip-based system for detecting free radicals, the first 3D atomic charge map of a key sensing material, and a large-scale study ...

US trade tribunal blocks Masimo’s bid to revive Apple Watch import ban, securing Apple’s redesigned smartwatch sales in the US market.